Live-attenuated respiratory syncytial virus (RSV) vaccines are highly immunogenic among HIV-exposed uninfected (HEU) pediatric patients, according to results of a study published in Open Forum ...

Shingles vaccine industry is projected to witness a CAGR of 10.1% during the period 2025-2034. This growth can be attributed ...

The global Veterinary Vaccines Market, valued at US$8.93 billion in 2023, is forecasted to grow at a robust CAGR of 6.1%, ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Valneva (NASDAQ:VALN – Free Report) had its price target cut by HC Wainwright from $19.00 to $18.00 in a report released on Thursday,Benzinga reports. They currently have a buy rating on the stock. HC ...

Studies conducted in mice have shown that the COVID-19 vaccine being developed by researchers at the University of São ...

Live attenuated vaccines are antigenic substances composed of a viable (living) pathogen, such as a virus or bacterium. The pathogen is altered so that it is less virulent or avirulent (attenuated).

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...